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We report here protein sequences of fossil hominids, from two
Neanderthals dating to 75,000 years old from Shanidar Cave in
Iraq. These sequences, the oldest reported fossil primate protein
sequences, are of bone osteocalcin, which was extracted and
sequenced by using MALDI-TOFTOF mass spectrometry. Through
a combination of direct sequencing and peptide mass mapping, we
determined that Neanderthals have an osteocalcin amino acid
sequence that is identical to that of modern humans. We also
report complete osteocalcin sequences for chimpanzee (Pan trog-
lodytes) and gorilla (Gorilla gorilla gorilla) and a partial sequence
for orangutan (Pongo pygmaeus), all of which are previously
unreported. We found that the osteocalcin sequences of Neander-
thals, modern human, chimpanzee, and orangutan are unusual
among mammals in that the ninth amino acid is proline (Pro-9),
whereas most species have hydroxyproline (Hyp-9). Posttransla-
tional hydroxylation of Pro-9 in osteocalcin by prolyl-4-hydroxy-
lase requires adequate concentrations of vitamin C (L-ascorbic
acid), molecular O2, Fe2, and 2-oxoglutarate, and also depends on
enzyme recognition of the target proline substrate consensus
sequence Leu-Gly-Ala-Pro-9-Ala-Pro-Tyr occurring in most mam-
mals. In five species with Pro-9–Val-10, hydroxylation is blocked,
whereas in gorilla there is a mixture of Pro-9 and Hyp-9. We
suggest that the absence of hydroxylation of Pro-9 in Pan, Pongo,
and Homo may reflect response to a selective pressure related to
a decline in vitamin C in the diet during omnivorous dietary
adaptation, either independently or through the common ancestor
of these species.
MALDI-TOFTOF  dietary adaptation  biomolecular preservation 
vitamin C  evolution
B iomolecules rarely survive intact in fossil bone and teeth, yetthey potentially provide key information on phylogenetic
relationships and adaptations. DNA survival in fossil bones and
teeth is especially rare in older samples, or in those from hotter
climates (1). However, proteins, and therefore phylogenetically
informative protein sequences, do persist in much older samples
(2, 3). Of the various bone proteins, osteocalcin has been shown
to survive particularly well in fossil bone, as demonstrated
recently when a complete sequence of fossil Bison priscus
osteocalcin was determined with protein extracted from excep-
tionally well preserved permafrost bones (4).
The protein itself is a small (Mr of 5.9 kDa), negatively charged
(pI of 4.0) molecule that is the second most abundant protein in
bone. The role of osteocalcin in bone metabolism is uncertain,
but it has -helical domains forming a tightly packed charged
molecule that coordinates Ca2 at the surface of the hydroxy-
apatite-like lattice of bone mineral crystals (5, 6). In all verte-
brate species so far investigated, the osteocalcin protein se-
quence is highly conserved within the central portion of the
molecule, containing the three -carboxyglutamic acid (Gla)
residues and Ca2 binding sites (Fig. 1) (6–8), whereas the N
terminus displays considerable variation and is the most genet-
ically informative region of the molecule.
Using a modified version of the methods described in ref. 4,
we have attempted to extract osteocalcin from three Nean-
derthals (specimens 2, 4, and 6) from Shanidar Cave, Iraq,
dating to 75,000 years old (12), and one Neanderthal [Vi-
76228 (Vi13.1), layer G3] from Vindija Cave, Croatia, dating
to40,000 years old (13). These data allowed comparison with
both published modern human osteocalcin sequences and
those we produced from archaeological, modern humans, and
other primates by using both MALDI-TOFTOF and Edman
sequencing.
Methods
Using themethodmodified from ref. 4, osteocalcin was extracted
and purified from bone powder by using Amprep C18 MiniCol-
umns after demineralization (0.5 M sodium EDTA, pH 8.0, 4 h,
25°C). An Applied Biosystems 4700 Proteomics Analyzer was
used for MALDI-TOFTOF analyses. Because the fossil sam-
ples are rare and precious specimens, we used minimal sample
sizes (55 mg of bone); therefore, the results reported here for
the Neanderthals are for one extraction per sample. Chimpanzee
(Pan troglodytes) and gorilla (Gorilla gorilla gorilla) samples were
obtained by H.P. from the Swedish Natural History Museum.De
novo sequencing of the samples from the modern species was
performed via a combination of peptide mass mapping and
collision-induced dissociation (CID) product ion MS of selected
peptides after tryptic digestion. For Edman sequencing, chim-
panzee (Pan troglodytes) and orangutan (Pongo pygmaeus) spec-
imens were obtained by permit from Yerkes Research Center
(Emory University, Atlanta). Osteocalcin was extracted and
purified from bone powder as described in ref. 7. Tryptic
digestion, HPLC purification of peptides, amino acid analysis,
and Edman sequencing followed ref. 7, except that 50- to
500-pmol peptide samples were analyzed on an ABI-477A
pulsed-liquid phase protein sequencer (Applied Biosystems).
Results
Unlike MS data from the permafrost samples (4), none of the
mass spectra of the fossil extracts contained the protonated
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molecule for osteocalcin. However, after tryptic digestion,
masses corresponding to expected tryptic peptides were ob-
served (Fig. 2). Of the Neanderthal samples analyzed, only
Shanidar 2 and 6 yielded measurable osteocalcin (Fig. 2).
Because of the exceptional limits of detection afforded by the
MALDI-TOFTOF mass spectrometric instrumentation, ion
intensities from a tryptic peptide from the Shanidar 2 protein
extract were sufficiently high for sequencing after high-energy
Fig. 1. Osteocalcin amino acid sequences for modern human (9, 10) and Neanderthal (Shanidar 2 Neanderthal). Chimpanzee (Pan troglodytes, Tai Forest, Ivory
Coast), gorilla (G. gorilla gorilla, East Africa), and orangutan (Pongo pygmaeus) sequences are also presented, as are selected data for monkey (Macaca
fascicularis) (7) and cow (Bos taurus) (11). -Carboxyglutamate residues at positions 17, 21, and 24 are indicated by ‘‘’’; hydroxyproline at position 9 is indicated
by ‘‘O.’’ Neanderthal residues shaded in graywere unable to be confirmed on CIDMS; however, results of peptidemassmapping of tryptic digests are consistent
with the first 19 residues being identical to those in the human protein. The new protein sequence data from the primates and Neanderthal were deposited in
the Swiss-Prot and TrEMBL database under accession numbers P84348 (Pan troglodytes), P84349 (G. gorilla gorilla), P84350 (Pongo pygmaeus), and P84351
(Neanderthal).
Fig. 2. MALDI mass spectra of tryptic digests of bone protein extracts from Neanderthals Shanidar 2 (a) and Shanidar 6 (b). Insets show the expanded regions
of the spectra. Only the ion withmz 2,822.2 from the Shanidar 2 sample was intense enough to perform CID MS, but peaks observed in a MALDI spectrum of
amodernhumanboneprotein digest corresponding to osteocalcin tryptic fragmentswere observed in both Shanidar 2 (mz 2,822.2, 20–43;mz 2,978.6, 20–44)
and Shanidar 6 (mz 2,274.8, 1–19; mz 2,978.8, 20–44) sample spectra.
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collision of the ion atmz 2,822 (Fig. 3). A characteristic pattern
of structurally diagnostic fragment ions was observed in product
ion spectra from Arg-20–Arg-43 from human (Fig. 3), chimpan-
zee, and gorilla extracts (data not shown). Submission of the
fragment ion data from the Shanidar 2 peptide to a MASCOT
MSMS ion search of the NCBInr database yielded a match to
peptide Arg-20–Arg-43 of human (and other) osteocalcin with
an ‘‘ions score’’ of 83 and a probability of 1e0.5 that this is a
random match. For human, chimpanzee, and gorilla samples,
CID spectra were obtained from Tyr-1–Arg-19 (human data not
shown) and Arg-20–Arg-43 (chimpanzee and gorilla data not
shown) peptides to identify the sequences (Figs. 1 and 3–6).
Discussion
The absence of the protonated molecule, and the success of MS
after tryptic digestion, suggests that ancient osteocalcin may be
partially preserved by condensation into a higher-molecular-
weight matrix. The trypsin cleavage product (Arg-20–Arg-43),
which spans most of the mineral binding domain (5, 6), was able
to be sequenced after CID MS (Figs. 1 and 3). The persistence
of the hydrophobic core and calcium binding surface provides
direct evidence that adsorption to mineral enhances long-term
preservation of ancient proteins. In addition to providing phy-
logenetic information, MALDI-MS also provides clues as to how
the osteocalcin molecule degrades. Osteocalcin peptides ex-
tracted from samples from both temperate and permafrost burial
environments demonstrate that in fossils with little or no colla-
gen remaining, the first 14 residues of osteocalcin are sometimes
missing (C.M.N.-M., unpublished data). These first 14 residues
are proline-rich; this finding supports the hypothesis that this
region could play a role in binding osteocalcin to collagen (14).
Previous attempts to extract collagen from both Shanidar and
Vindija Neanderthals proved unsuccessful (M.P.R., unpublished
data), and although a peptide with an mz corresponding to the
protonated Tyr-1–Arg-19 fragment observed in spectra of the
human sample was detected in the Shanidar 6 sample (but not
in Shanidar 2), this was too weak for successful CIDMS (Fig. 2).
This 1–19 peptide is where most variations between mammal
species are observed (8) (Fig. 1), and whereas modern humans
and (based on the peptide mass determinations) Neanderthals
have identical sequences, gorilla was found to differ by only a
single posttranslationally modified amino acid, with a mixture of
Hyp and Pro at the ninth position (Figs. 1 and 4).
Chimpanzee shares Pro-9 with orangutan and Homo but has
Thr at position 15 (Figs. 1 and 5). Substitution of Thr-15 for
Pro-15 is readily explained by a single-base change of C3 A at
the first position on the 5 side of the codon for Pro-15 in the
chimpanzee osteocalcin gene. This mutation must have occurred
in the chimpanzee branch after divergence from the ancestral
hominid lineage, because the Pro-15 has been conserved in
Homo as well as in primates with earlier divergence: gorilla,
orangutan, and Old World monkey, M. fascicularis (Fig. 6). At
position 19, Lys-19 occurs in Old World monkey and orangutan
but has mutated to Arg-19 in chimpanzee, gorilla, and Homo.
The simplest explanation is a single A 3 G base change in the
second position of the Lys codon, yielding the Arg codon, which
must have occurred after divergence of orangutan. At position
10, Ala-10 occurs in Old World monkey but changed to Val-10
in orangutan, gorilla, chimpanzee, and Homo. Again, a single-
base change in the osteocalcin gene of C 3 T in the second
position of the Ala-10 codon would yield the Val codon (Fig. 6).
The lack of hydroxylation of Pro-9 in chimpanzee, orangutan,
and humanHomo osteocalcin is intriguing (i) because it is a
posttranslational variation distinct from the evolution of the
osteocalcin gene sequence, and (ii) because of the distinctly
different properties of the two classes of prolyl-4-hydroxylases
(P4Hs) that may target osteocalcin. P4Hs (EC 1.14.11.2) are
discriminated by their protein substrate preferences, Km and
kinetic properties, and subcellular localization. P4Hs all require
molecular O2, L-ascorbic acid, 2-oxoglutarate, and Fe2 to
catalyze the hydroxylation of Pro in peptides (15, 16). Collagen
P4Hs (Col-P4Hs) act in the endoplasmic reticulum to modify
nascent procollagen chains. The tetrameric enzyme comprises
two  subunits (P4HA1, P4HA2, or P4HA3) and two  subunits
Fig. 3. CID product ion spectra of peptide Arg-20–Arg-43 frommodern human (a) and Shanidar 2 (b) Neanderthal. Precursor ion, MH, is represented by the
peak at the highestmz (2,822). Peptide sequence ions produced on cleavage of peptide bonds are labeled by using Roepstorff nomenclature (4). The spectrum
from the Neanderthal sample contains a less complete y ion series than that of the modern human, probably as a result of a much smaller quantity of protein
surviving in the fossil. The y ion series given by both samples are consistent with the sequence Arg-Glu-Val-Cys-Glu-Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-
His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg. The peak marked with * is unassigned.
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(P4HBprotein disulfide isomerase). Hydroxyproline accounts
for10% of the total amino acid composition of type I collagen
and is essential for stability of the collagen triple helix. HIF-1
(hypoxia-inducible factor 1) P4Hs (HIF-P4Hs) are cytoplasmic
and nuclear, targeting Pro-524 and Pro-402 in HIF-1 (17–19).
Hydroxyproline at one or both of these sites facilitates binding
to the von Hippel–Lindau (VHL) protein that then initiates the
ubiquitination and proteasome-mediated degradation of HIF-1
(20). HIF-P4Hs serve as critical sensors for the concentration of
dissolved atmospheric molecular O2 because of their poor
affinity for O2 (Km 230–250 M); in contrast, Col-P4H1 binds
O2 strongly (Km  40 M) (16). Under hypoxic conditions,
HIF-P4Hs are inactive and thus the nonhydroxylated form of
HIF-1 accumulates in cells and activates the transcription of
genes essential for cell and tissue responses to hypoxia.
The peptide substrate specificities for the HIF-P4Hs (Leu-X-
X-Leu-Ala-Pro*-AlaTyr) (16, 19) suggest that they may hy-
droxylate Pro-9 in osteocalcin (Leu-Gly-Ala-Pro*-AlaVal)
(Fig. 1) more efficiently than the Col-P4Hs, which target the
Gly-X-Pro*-Gly sequence (15). Both P4H classes are expressed
in osteoblasts where osteocalcin and collagen type I are synthe-
sized, but the subcellular localization of osteocalcin hydroxyla-
tion has not been established. Interestingly, 14 of 18 vertebrate
osteocalcins with a conserved Pro-9 are hydroxylated to Hyp-9,
and 13 of these 14 have the sequence Hyp-9–Ala-10 (refs. 4, 7,
and 8; P.V.H., unpublished data), whereas gorilla is the lone
exception with Hyp-9–Val-10. In all four species where Pro-9 is
not hydroxylated, the Pro-9–Val-10 sequence occurs. Thus,
hydroxylation of Pro-9 is strongly favored by Ala-10 and resisted
by Val-10, pointing to properties of the responsible P4H enzyme.
Fig. 4. MALDImass spectrumof tryptic digest fromgorilla (G. gorilla gorilla) boneprotein extract. The Inset shows the expanded regionof the spectrum. Tryptic
fragments were observed suggesting a mixture of Hyp (mz 2,289.5) and Pro (mz 2,273.7) at the ninth position in the 1–19 peptide. Other tryptic peptides
observed support the assignment of the proposed sequence (Fig. 1) (mz 738.3, 44–49; mz 2,665.7, 21–43; mz; 2,821.8, 20–43; mz 2,977.8, 20–44).
Fig. 5. CID product ion spectrum of peptide Tyr-1–Arg-19 from chimpanzee (Pan troglodytes). Precursor ion, MH, is represented by the peak at the highest
mz (2,278.0). Peptide sequence ions produced on cleavage of peptide bonds are labeled by using Roepstorff nomenclature (4); only y ions are labeled. Insets
show the expanded region of the spectrum. The sequence given by the y ions series is Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Thr-Leu-Glu-
Pro-Arg.
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The known sensitivity of proline hydroxylation to concentrations
of O2 (for the HIF-P4Hs) and L-ascorbic acid (for all P4Hs)
results in partial hydroxylation and ProHyp mixtures at the
target sites (16, 21). The Pro-9Hyp-9 mixture observed in
gorilla osteocalcin (Fig. 4) may be explained in this way.
L-gulonolactone oxidase, a microsomal enzyme that catalyzes
the terminal step in the biosynthesis of L-ascorbic acid is missing
in most primates. Consequently, these organisms are prone to
scurvy if the concentration of vitamin C in the diet falls.
Paleopathological markers for the diagnosis of scurvy in ancient
human skeletons have been described (22), but there is no
paleopathological evidence of scurvy (or any other vitamin-
specific dietary deficiency) among the Neanderthals or other
fossil hominids. A molecule of L-ascorbic acid is consumed for
each hydroxylation event (23). With an omnivorous dietary
adaptation, especially a shift toward greater carnivory, there are
periods when dietary vitamin C would either not be available or
present only in reduced amounts. Recent humans, chimpanzees,
and orangutans are omnivores; therefore, this difference in the
posttranslational hydroxylation of osteocalcin compared to the
herbivorous gorilla may relate to increased selective pressure to
limit hydroxylation to counteract periods of low dietary vitamin
C. Such a dietary adaptation could be inherited from the
common chimpanzeehuman ancestor or could have arisen
independently. Analysis of Hyp in osteocalcin and collagen of
other Homo species may resolve this.
The data presented here illustrate the great potential of fossil
protein sequences to provide behavioral, phenotypic, and phy-
logenetic information, especially when compared to related
extant species. Now that we have demonstrated that it is possible
to extract and sequence intact fossil proteins from fossil homi-
nids, it opens the possibility of sequencing osteocalcin and other
proteins from other, earlier, hominid species to better under-
stand the palaeobiological patterning of the hominid line.
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